Commercial payers expect to pay $1.1B this year on member rebates
(By Jakob Emerson for Becker’s Hospital Review) Payers are expecting to issue a total of about $1.1 billion in medical
Read More
Health Care Finance
New Alzheimer’s Drugs Spark Hope for Patients and Cost Concerns for Medicare
(By Juliette Cubanski and Tricia Neuman for Kaiser Family Foundation published May 18, 2023) The FDA’s accelerated approval of Aduhelm
Read MorePBMs, the Brokers Who Control Drug Prices, Finally Get Washington’s Attention
(By Arthur Allen for KFF Health News) For two decades, patients and physicians eagerly awaited a lower-cost version of the
Read MoreStandardized Plans in the Health Care Marketplace: Changing Requirements
(By Karen Pollitz, Justin Lo, and Rayna Wallace for Kaiser Family Foundation Published: May 08, 2023) For the 2023 coverage
Read More‘Patients are not hot potatoes’: How the fight over dialysis coverage is putting kidney failure patients at risk
(By Carrie Arnold for STAT) As soon as she heard the Supreme Court decision, LaVarne Burton began to worry. As
Read MoreBiden Administration Issues New Warning About Medical Credit Cards
(By Noam N. Levey for KFF Health News) The Biden administration on Thursday cautioned Americans about the growing risks of
Read MorePennsylvania bans out-of-pocket costs for breast cancer screenings, genetic testing
(By Jakob Emerson for Becker’s Hospital Review) Pennsylvania Gov. Josh Shapiro signed legislation May 1 that will require all payers
Read MoreMore enrollees choosing higher-premium Medicare Advantage, Part D plans
(Rylee Wilson for Becker’s Hospital Review) The average premium cost for Medicare Advantage plans sold on eHealth increased from $6
Read MoreOIG: Duplicate Medicare, VA payments cost Medicare $128M
(By Rylee Wilson for Becker’s Hospital Review) Medicare could have saved $128 million in duplicate claims payments with a better
Read MoreAHIP, AHA point fingers on cost of specialty drugs
(By Rylee Wilson for Becker’s Hospital Review) Insurer groups say hospitals are to blame for higher costs of specialty drugs,
Read More